Proporsi peresepan probiotik pada gastroenteritis akut pasien pediatri di bangsal rawat inap RS X pada Februari 2015

Authors

  • Dita Maria Virginia Faculty of Pharmacy, Sanata Dharma University

DOI:

https://doi.org/10.12928/pharmaciana.v6i2.3902

Keywords:

probiotic, pediatric, acute gastroenteritis

Abstract

Pediatric patients are one of the target groups of the National Health System in Indonesia that requires special attention in therapy because their anatomy physiology was immature. A lot of probiotics indicated for acute gastroenteritis (AGE) for pediatric patients. Probiotic prescribing includes the types of probiotic, dosage and duration for AGE has not been discussed clearly. The aim of our study was to determine the proportion of probiotic that have prescribed for acute gastroenteritis topediatric agedin hospitalized. This study was analytical observational with cross sectional design. Data was obtained retrospectively with non-purposive sampling.Samplesize was based on cross-sectional design calculation and obtained a number of 200 medical records from Hospital X, IndonesiaonFebruary 2015. This study used secondary data from medical records. Data collected was patient identity, patientaged, probiotic prescribing includes the types of probiotic, dosage and duration. Data have been analyzed in descriptive and Mann-Whitney to observe the difference between types of probiotic, dosage and duration probiotic used topediatric aged. This study showed this hospital only used 5 probiotic brands. Group aged <2 years is more used of 3 types of probiotic species while at the age of> 2 years is prefer to use 6 types. The mean dose of probiotic is greater in the group aged >2 years. Probiotic duration in the group <2 years is for 4 days while in those aged >2 years in duration 5 days. The number of cases that do not fit with the recommended dose packs is more commonly found at age <2 years. There is a different proportion between type of probiotic (p=0.000), dose of probiotic (p=0.040), and probiotic duration (p=0.008) with pediatric aged. There was a statistically significant difference between types of probiotic, dosage and duration probiotic used to pediatric aged.

Downloads

Published

2016-10-20

Issue

Vol. 6 No. 2 (2016): Pharmaciana

Section

Clinical and Community Pharmacy

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.